Baeker T R, Rothstein T L
J Immunol. 1985 May;134(5):3532-8.
Human malignant B lymphocytes were identified that proliferate in response to small doses of anti-immunoglobulin. Proliferation was induced by monoclonal mouse anti-HIgM, polyclonal goat anti-HIgM, and F(ab')2 fragments thereof, in vitro, and was not accompanied by immunoglobulin secretion. Proliferation was found to be unaffected by T cell depletion and was not enhanced by supplementation with B cell growth factor. Culture fluids from unstimulated malignant lymphocytes as well as from malignant lymphocytes stimulated with anti-HIgM contained no measurable B cell growth factor activity. Thus, proliferation of these malignant lymphocytes was not dependent on the presence of T lymphocytes and was independent of the presence of B cell growth factor. These results imply that B cell stimulatory factors may not be required for proliferation of all human B lymphocytes. Moreover, these results imply that treatment with anti-immunoglobulin reagents may be inappropriate for some B lymphocyte malignancies.
已鉴定出人类恶性B淋巴细胞可对小剂量抗免疫球蛋白产生增殖反应。在体外,单克隆小鼠抗人IgM、多克隆山羊抗人IgM及其F(ab')2片段可诱导其增殖,且不伴有免疫球蛋白分泌。发现增殖不受T细胞耗竭的影响,补充B细胞生长因子也不会增强增殖。未刺激的恶性淋巴细胞以及用抗人IgM刺激的恶性淋巴细胞的培养液中均未检测到可测量的B细胞生长因子活性。因此,这些恶性淋巴细胞的增殖不依赖于T淋巴细胞的存在,也独立于B细胞生长因子的存在。这些结果表明,并非所有人类B淋巴细胞的增殖都需要B细胞刺激因子。此外,这些结果表明,抗免疫球蛋白试剂治疗可能不适用于某些B淋巴细胞恶性肿瘤。